In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular...
In this commentary, Charlotte Owens, MD, reviews data from the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, including study findings on treatment options for...
In this Editorial, Editorial Board Member Michael J. Bloch, MD, reflects on a 1985 article from Consultant’s archives about how to properly use the laboratory to monitor drug therapy among patients with...
In this video, Michael Bloch, MD, discusses a guide for primary care physicians to make a prompt diagnosis and treat patients with pulmonary arterial hypertension. He spoke on this topic at the Practical...
In this video, Michael Bloch, MD, discusses identifying and treating patients with pulmonary arterial hypertension. He spoke on this topic at the Practical Updates for Primary Care 2021 Virtual Series. ...
Is pulmonary artery denervation via a therapeutic intravascular ultrasonic system a safe and effective treatment option for patients with PAH? In this Q&A, Alex Rothman, BM BCh, PhD, highlights what he and...
In this Q&A, Dr Machado answers our questions about the impact that biologic disease-modifying antirheumatic drugs have in axial spondyloarthritis remission.
In this video, Antonio Anzueto, MD, talks about the next steps in his research into treatment options for patients with symptomatic COPD who are at high risk of exacerbations.
In this video, Antonio Anzueto, MD, gives an overview of his team's study that compared fluticasone furoate/umeclidinium/vilanterol in a single inhaler with tiotropium among patients with symptomatic COPD,...
